Model DetailsLung tumor
Model Name |
Lung tumor | Strain |
A |
Tumor Inducing Agent(s) |
None (spontaneous) |
Tumor Synonyms |
primary adenomatous alveologenic lung tumor • lung tumor • lung nodule |
Strain Synonyms |
Strong's albino • strain A |
| Organ Affected | Sex | Frequency | Age Of Detection | Additional Information Expand all Collapse all | Reference |
|---|---|---|---|---|---|
| Lung | Unspecified |
high |
1 year |
|
Shimkin MB, Adv Cancer Res 1975;21():1-58 |
| Lung | Unspecified |
observed |
3-4 months |
|
Shimkin MB, Adv Cancer Res 1975;21():1-58 |
| Lung | Unspecified |
~100 |
24 months |
|
Shimkin MB, Adv Cancer Res 1975;21():1-58 |
| Lung | Unspecified |
71% |
23 months |
|
Shimkin MB, Adv Cancer Res 1975;21():1-58 |
| Lung | Unspecified |
21% (4 of 19 mice) |
28-32 weeks |
|
Shimkin MB, Adv Cancer Res 1975;21():1-58 |
| Lung | Unspecified |
11% (15 of 138 mice) |
|
Shimkin MB, Adv Cancer Res 1975;21():1-58 | |
| Lung | Unspecified |
19% (18 of 94 mice) |
6 months |
|
Shimkin MB, Adv Cancer Res 1975;21():1-58 |
| Lung | Unspecified |
40% (12 of 30 mice) |
>1 year |
|
Shimkin MB, Adv Cancer Res 1975;21():1-58 |
| Lung | Mixed Population |
17% (24 of 141 mice) |
6 months |
|
Shimkin MB, Adv Cancer Res 1975;21():1-58 |
| Lung | Mixed Population |
0% (0 of 20 mice) |
2 months |
|
Shimkin MB, Adv Cancer Res 1975;21():1-58 |
| Lung | Mixed Population |
1.7% (1 of 60 mice) |
3 months |
|
Shimkin MB, Adv Cancer Res 1975;21():1-58 |
| Lung | Mixed Population |
3.0% (2 of 66 mice) |
4 months |
|
Shimkin MB, Adv Cancer Res 1975;21():1-58 |
| Lung | Mixed Population |
2.9% (2 of 69 mice) |
5 months |
|
Shimkin MB, Adv Cancer Res 1975;21():1-58 |
| Lung | Mixed Population |
7.2% (6 of 83 mice) |
6 months |
|
Shimkin MB, Adv Cancer Res 1975;21():1-58 |
| Lung | Mixed Population |
11% (13 of 115 mice) |
7 months |
|
Shimkin MB, Adv Cancer Res 1975;21():1-58 |
| Lung | Mixed Population |
13% (16 of 127 mice) |
8 months |
|
Shimkin MB, Adv Cancer Res 1975;21():1-58 |
| Lung | Mixed Population |
25% (30 of 121 mice) |
9 months |
|
Shimkin MB, Adv Cancer Res 1975;21():1-58 |
| Lung | Mixed Population |
32% (68 of 212 mice) |
10 months |
|
Shimkin MB, Adv Cancer Res 1975;21():1-58 |
| Lung | Mixed Population |
39% (41 of 106 mice) |
11 months |
|
Shimkin MB, Adv Cancer Res 1975;21():1-58 |
| Lung | Mixed Population |
40% (71 of 178 mice) |
12 months |
|
Shimkin MB, Adv Cancer Res 1975;21():1-58 |
| Lung | Mixed Population |
48% (50 of 104 mice) |
13 months |
|
Shimkin MB, Adv Cancer Res 1975;21():1-58 |
| Lung | Mixed Population |
43% (57 of 132 mice) |
14 months |
|
Shimkin MB, Adv Cancer Res 1975;21():1-58 |
| Lung | Mixed Population |
67% (129 of 192 mice) |
15 months |
|
Shimkin MB, Adv Cancer Res 1975;21():1-58 |
| Lung | Mixed Population |
67% (29 of 43 mice) |
16 months |
|
Shimkin MB, Adv Cancer Res 1975;21():1-58 |
| Lung | Mixed Population |
62% (31 of 50 mice) |
17 months |
|
Shimkin MB, Adv Cancer Res 1975;21():1-58 |
| Lung | Mixed Population |
77% (105 of 136 mice) |
18 months |
|
Shimkin MB, Adv Cancer Res 1975;21():1-58 |
| Lung | Male |
observed |
8 months |
|
Shimkin MB, Adv Cancer Res 1975;21():1-58 |